We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04973137
Brief Title: A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis (AFFIRM-AL)

First Submitted : July 1, 2021
First Submitted that Met QC Criteria : July 21, 2021
First Posted : July 22, 2021

Last Update Submitted that Met QC Criteria : September 6, 2022
Last Update Posted : September 7, 2022